Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 10490 records

$999,793.00

Feb 1, 2020

Individual or sole proprietorship

Agreement:

Operating Grant: COVID-19 - Vaccines

Agreement Number:

154683

Duration: from Feb 1, 2020 to Jan 31, 2022
Description:

The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:

• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Saskatoon, Saskatchewan, CA S7N 5A2

$1,000,000.00

Feb 1, 2020

Individual or sole proprietorship

Agreement:

Operating Grant: COVID-19 - Therapeutics

Agreement Number:

154678

Duration: from Feb 1, 2020 to Jan 31, 2022
Description:

The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:

• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, Ontario, CA M5B 1W8

$1,000,000.00

Feb 1, 2020

Individual or sole proprietorship

Agreement:

Operating Grant: COVID-19 - Transmission dynamics/animal host/modeling

Agreement Number:

154695

Duration: from Feb 1, 2020 to Jan 31, 2022
Description:

The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:

• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Vancouver, British Columbia, CA V6T 1Z1

$886,090.00

Feb 1, 2020

Individual or sole proprietorship

Agreement:

Operating Grant: COVID-19 - Therapeutics

Agreement Number:

154680

Duration: from Feb 1, 2020 to Jan 31, 2022
Description:

The specific objectives of the Canadian 2019-nCoVrapid research funding opportunity are to:

• Contribute to the global response to the 2019-nCoV outbreak;
• Enhance local, national and/or international collaborative efforts to mitigate the rapid spread of 2019-nCoV and its potential negative consequences;
• Strengthen the understanding of the impact of 2019-nCoV on individuals and communities; and
• Provide evidence to inform clinical and public health response, and/or decision-making and planning at national and international levels.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, Ontario, CA H3C 3J7

$48,600.00

Feb 1, 2020

For-profit organization

Agreement:

Development of 3D ultrasound technology for integration in the permanent breast seed implant brachytherapy treatment

Agreement Number:

939730

Duration: from Feb 1, 2020 to Feb 28, 2021
Description:

The primary aim is to produce a market-ready device that can be incorporated into the clinical permanent breast seed implant treatment.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Calgary, Alberta, CA T3C 2M5

Not-for-profit organization or charity

Agreement:

National Network of Legal Clinics for the Arts - Follow-up Meetings

Agreement Number:

1327952

Duration: from Feb 1, 2020 to Mar 15, 2020
Description:

Canada Cultural Investment Fund

Organization: Canadian Heritage
Program Name: Canada Cultural Investment Fund - The First Spark Initiative
Location: Toronto, Ontario, CA

$40,875.00

Jan 7, 2020

For-profit organization

Agreement:

Building Awareness of dicentra in the US and Europe

Agreement Number:

943042

Duration: from Jan 7, 2020 to Dec 31, 2020
Description:

With trade show presence, marketing, prospect visits and association membership we will greatly increase the awareness of our clinical trial services in the US Midwest, Northeast and in Switzerland, France and the United Kingdom.

Organization: National Research Council Canada
Program Name: CanExport SMEs
Location: Toronto, Ontario, CA M5S 2B7

For-profit organization

Agreement:

Internet-based Cognitive Behavioural Therapy Platform

Agreement Number:

941003

Duration: from Jan 6, 2020 to Dec 31, 2020
Description:

Developing internet-based Cognitive Behavioural Therapy Program for Chronic Pain to teach patients pain management skills, skills to reduce and prevent symptoms of depression and anxiety and to build an active lifestyle.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Thornhill, Ontario, CA L4J 1W3

$82,500.00

Jan 1, 2020

Individual or sole proprietorship

Agreement:

Fellowship - Priority Announcement: Gastroenterology

Agreement Number:

149741

Duration: from Jan 1, 2020 to Dec 31, 2022
Description:

The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) in partnership with the Canadian Association of Gastroenterology (CAG) will provide funding for applications that are determined to be relevant to the research priority areas as described below:
applications that relate specifically to biomedical or clinical research related to Gastroenterology that will contribute to building increased Canadian research capacity in the field.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, Ontario, CA M5G 1X8

$165,288.00

Jan 1, 2020

Individual or sole proprietorship

Agreement:

Team Grant: ERA-Net PerMed

Agreement Number:

152517

Duration: from Jan 1, 2020 to Dec 31, 2022
Description:

Support translational research projects in the field of Personalised Medicine;
Encourage and enable interdisciplinary collaborations towards implementation of Personalised Medicine, in combining pre-clinical and/or clinical research with computational components and research on relevant ethical, legal and social aspects (ELSA) and/or research on the optimisation of the health care systems; and
Encourage collaboration between academia (research teams from universities, higher education institutions, public research performing institutions), clinical/public health research (research teams from hospital/ public health institutions, healthcare settings and other healthcare organisations) and private partners.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Montreal, Quebec, CA H3G 1A4